FDA recall D-0339-2019
Pfizer Inc. · Class II · drug
Product
Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
Reason for recall
Superpotent Drug.
Distribution
Nationwide within the United States
Key facts
- Status
- Terminated
- Initiation date
- 2018-12-06
- Report date
- 2018-12-26
- Termination date
- 2020-10-08
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- New York, NY, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0339-2019